Pardanani, A
Reichard, K K
Zblewski, D
Abdelrahman, R A
Wassie, E A
Morice II, W G
Brooks, C
Grogg, K L
Hanson, C A
Tefferi, A
Chen, D
Article History
Received: 22 September 2015
Revised: 9 November 2015
Accepted: 7 December 2015
First Online: 18 December 2015
Competing interests
: AP received a research grant from Stemline therapeutics for preclinical study of the CD123-targeting drug, SL-701. CB is an employee of Stemline Therapeutics.